MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Novavax Company Profile (NASDAQ:NVAX)

Consensus Ratings for Novavax (NASDAQ:NVAX) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $13.68 (90.78% upside)

Analysts' Ratings History for Novavax (NASDAQ:NVAX)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Piper JaffrayReiterated RatingOverweight$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016WedbushReiterated RatingOutperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Chardan CapitalReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016JPMorgan Chase & Co.Lower Price TargetOverweight$14.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016FBR & Co.Reiterated RatingOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015Citigroup Inc.Lower Price TargetBuy$18.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015GuggenheimInitiated CoverageMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/2/2015Ladenburg ThalmannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Janney Montgomery ScottReiterated Rating$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2015GMP SecuritiesInitiated CoveragePositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Novavax (NASDAQ:NVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/4/2016Q1($0.27)($0.29)$10.39 million$4.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415($0.14)($0.29)$8.07 million$5.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.09)($0.12)$10.59 million$6.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.09)($0.08)$9.90 million$14.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.11)($0.10)$9.70 million$9.88 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q4 14($0.08)($0.13)$9.60 million$6.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.07)($0.08)$9.20 million$8.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.07)($0.08)$8.74 million$8.26 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.07)($0.07)$3.80 million$7.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2014Q413($0.08)($0.07)$6.22 million$8.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.06)($0.09)$4.56 million$4.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.06)($0.08)$4.45 million$3.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.06)($0.07)$5.54 million$3.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012($0.04)($0.06)$5.85 million$4.57 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2012Q312($0.05)($0.05)$7.59 million$5.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2012($0.07)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2012($0.04)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2012($0.04)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2011($0.06)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2011($0.08)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.07)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/28/2011($0.09)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Novavax (NASDAQ:NVAX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.27)($0.13)($0.22)
Q2 20163($0.28)($0.13)($0.19)
Q3 20163($0.23)($0.16)($0.19)
Q4 20163($0.24)($0.16)($0.19)
Q1 20171($0.21)($0.21)($0.21)
Q2 20171($0.23)($0.23)($0.23)
Q3 20171($0.22)($0.22)($0.22)
Q4 20171($0.11)($0.11)($0.11)
(Data provided by Zacks Investment Research)
Dividend History for Novavax (NASDAQ:NVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Novavax (NASDAQ:NVAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/6/2016Gary C EvansDirectorSell18,998$6.50$123,487.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Gary C EvansDirectorSell50,000$5.41$270,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Stanley C ErckCEOSell424,778$5.19$2,204,597.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Barclay A. PhillipsCFOBuy405$4.38$1,773.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Gregory M. GlennSVPBuy2,369$4.38$10,376.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Stanley C. ErckCEOBuy2,072$4.38$9,075.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015John A Herrmann IIISVPSell27,945$8.64$241,444.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Gary C EvansDirectorSell20,000$11.24$224,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Barclay A. PhillipsCFOSell28,656$13.06$374,247.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Gregory M. GlennSVPSell15,000$13.52$202,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Gary C EvansDirectorSell6,002$13.56$81,387.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015James F YoungDirectorSell50,000$9.47$473,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Rajiv I ModiDirectorSell433,053$9.01$3,901,807.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2015Rajiv I ModiDirectorSell11,185$9.00$100,665.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Rajiv I ModiDirectorSell551,081$8.97$4,943,196.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Rajiv I ModiDirectorSell47,531$8.93$424,451.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Rajiv I ModiDirectorSell206,175$8.93$1,841,142.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Rajiv I ModiDirectorSell504,681$8.92$4,501,754.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Rajiv I ModiDirectorSell3,500,000$8.74$30,590,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015Barclay A PhillipsCFOBuy8,388$2.28$19,124.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015John TrizzinoSVPBuy6,611$3.63$23,997.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015Stanley C ErckCEOBuy6,122$2.28$13,958.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Gary C EvansDirectorSell46,701$5.72$267,129.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Gary C EvansDirectorSell30,000$5.77$173,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Rajiv I ModiDirectorSell518,889$5.02$2,604,822.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Rajiv I ModiDirectorSell1,481,111$5.00$7,405,555.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Barclay A PhillipsCFOBuy5,000$4.11$20,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Timothy Jon HahnSVPBuy2,500$4.05$10,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Gregory M GlennSVPSell16,809$4.16$69,925.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Timothy Jon HahnSVPBuy9,000$4.17$37,530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Barclay A PhillipsCFOBuy8,788$2.28$20,036.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Russell P WilsonSVPBuy4,989$2.28$11,374.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Stanley C ErckCEOBuy6,788$2.28$15,476.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014John TrizzinoSVPBuy5,500$4.51$24,805.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014John TrizzinoSVPBuy16,500$4.51$74,415.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Barclay PhillipsCFOBuy5,000$4.25$21,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Richard DouglasDirectorBuy50,000$4.33$216,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Stanley ErckCEOBuy10,000$4.27$42,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Pharmaceuticals Ltd Cadilamajor shareholderSell3,000,000$4.95$14,850,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Barclay PhillipsCFOBuy9,868$2.29$22,597.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Stanley ErckCEOBuy11,868$2.29$27,177.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Timothy Jon HahnSVPBuy9,416$2.29$21,562.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Richard DouglasDirectorBuy50,000$1.90$95,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Timothy Jon HahnSVPBuy21,000$1.88$39,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Gregory M GlennInsiderBuy2,000$1.92$3,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2013James F YoungDirectorBuy100,000$1.91$191,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2013James F YoungDirectorBuy100,000$2.03$203,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Novavax (NASDAQ:NVAX)
DateHeadline
06/29/16 05:27 PMAnalyst Rating Update on Novavax (NVAX) - Trade Calls
06/29/16 05:27 PMPerformance to see: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/29/16 08:22 AMMovers to Watch For: NVIDIA Corporation (NASDAQ:NVDA), Novavax, Inc. (NASDAQ:NVAX), Taiwan Semiconductor ... - iStreetWire
06/29/16 08:22 AMAnalyst Rating Fluctuations to Observe: Novavax, Inc. (NASDAQ:NVAX) , Zoetis Inc. (NYSE:ZTS) - Street Updates
06/29/16 08:22 AMNovavax Inc. (NVAX) Jumps 11.16% on June 28 - Equities.com
06/29/16 08:22 AMNovavax Attempts To Clear The $7 Hurdle - Benzinga
06/28/16 05:30 PMNovavax Attempts To Clear The $7 Hurdle
06/28/16 08:07 AMMylan’s Profits: Can You Expect Changes? -
06/28/16 02:36 AMWatch These 5 Huge Put Purchases In Tuesday Trade - Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session. Novavax, Inc. (NASDAQ: NVAX) Aug16 5.0 Puts Sweep: 1210 @ ...Full story available on Benzinga.com
06/27/16 09:45 AMNovavax, Inc. (NASDAQ:NVAX) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 10:04 AMPerformance Overview of the company: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/24/16 02:06 PMBrexit Bargains: 3 Clinical-Stage Biotechs to Buy - A global sell-off in stocks is causing companies with little exposure to the EU to drop. With key U.S. catalysts on deck, investors might want to scoop up shares in Novavax, Inc., Kite Pharma, and Flexion Therapeutics.
06/22/16 10:18 AMHC Stocks Assessment: Novavax, Inc. (NASDAQ:NVAX), Eli Lilly and Co (NYSE:LLY) - share market updates (press release)
06/20/16 05:22 PMLifelock Inc (NYSE:LOCK) & Novavax, Inc. (NASDAQ:NVAX) Sizzling Stock Alert - Wall Street 24
06/20/16 07:10 AMAnalyst's Noticeable Buzzers: Novavax, Inc. (NASDAQ:NVAX) , TherapeuticsMD, Inc. (NYSEMKT:TXMD) - Street Updates
06/17/16 08:20 AMNovavax, Inc. (NASDAQ:NVAX) Insider Activities Are in the Air
06/17/16 07:39 AMNovavax Recognized by Washington Post as Top Workplace - - [at noodls] - (GLOBE NEWSWIRE via COMTEX) --GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third consecutive year, it has been recognized as a Top Workplace ...
06/17/16 07:30 AMNovavax Recognized by Washington Post as Top Workplace - [GlobeNewswire] - GAITHERSBURG, Md., June 17, 2016-- Novavax, Inc., today announced that, for the third consecutive year, it has been recognized as a Top Workplace for 2016.. “At Novavax, we strive to create an environment ...
06/16/16 05:44 PMAnalyst Overview on These Stocks: Novavax, Inc. (NASDAQ:NVAX), Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) - Beacon Chronicle
06/15/16 05:31 PMTrending Analyst Recommended Stock: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/15/16 05:31 PMHC Stocks Newsbeat: Novavax, Inc. (NASDAQ:NVAX), Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) - share market updates (press release)
06/14/16 10:19 AMAnalysts Watch-list Stocks: Novavax, Inc. (NASDAQ:NVAX) , Brookdale Senior Living Inc. (NYSE:BKD) - Street Updates
06/14/16 06:22 AMHere's Why Novavax's Stock Could Double -
06/13/16 08:30 AMHC Stocks in Focus: Novavax, Inc. (NASDAQ:NVAX), Zoetis Inc (NYSE:ZTS) - share market updates (press release)
06/13/16 08:00 AM5 Top Stocks to Buy in June -
06/11/16 08:26 AMPrice Target Review: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/10/16 05:51 PMNovavax Nears Vaccine Approval, Manufacturing, Sales And Profits - Seeking Alpha
06/10/16 04:24 PMNOVAVAX INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/10/16 08:30 AMHC Stocks in the Rumor: Novavax, Inc. (NASDAQ:NVAX), Johnson & Johnson (NYSE:JNJ) - share market updates (press release)
06/10/16 08:30 AMNovavax, Inc. (NASDAQ:NVAX) Fundamental Star Rating Report - CML News
06/09/16 05:54 PMAnalyst Overview: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/09/16 08:28 AMAnalysts Watch-list Stocks: Novavax, Inc. (NASDAQ:NVAX) , Hologic, Inc. (NASDAQ:HOLX) - Street Updates
06/08/16 05:55 PMAnalyst Recommended Stock: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/08/16 08:33 AMAnalyst Rating Trends to Observe: Novavax, Inc. (NASDAQ:NVAX) , Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) - Street Updates
06/08/16 08:33 AMHC Stocks in Focus: Novavax, Inc. (NASDAQ:NVAX), Mast Therapeutics Inc (NYSEMKT:MSTX) - share market updates (press release)
06/08/16 08:02 AMResearch Coverage Scans Stocks on the Biotechnology Industry for Today -
06/07/16 05:47 PMAnalyst Buzz: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/07/16 05:47 PMUpdated Analysts Rating Report: Novavax, Inc. (NASDAQ:NVAX) , The Medicines Company (NASDAQ:MDCO) - Street Updates
06/07/16 05:47 PMNOVAVAX INC. (NASDAQ:NVAX) Financial Condition Compared to S&P 500 - CML News
06/07/16 05:30 PM3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too - Novavax, Agile Therapeutics, and Flexion Therapeutics have caught the fancy of some of the biggest investors on the planet, and after researching them, they're becoming favorites of mine, too.
06/07/16 08:14 AMEarnings Expectation Watch List: B2Gold Corp. (NYSEMKT:BTG), Novavax, Inc. (NASDAQ:NVAX) - Beacon Chronicle
06/06/16 05:28 PMStock to Focus on: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/06/16 10:30 AM3 Reasons Behind Novavax, Inc.'s Superior Performance in May - Novavax shareholders have these three catalysts to thank for their stocks' 16% rise last month.
06/06/16 09:14 AMWill Novavax, Inc. (NASDAQ:NVAX) Surprise Analysts? - Investor Newswire
06/06/16 09:14 AMEarnings in Focus: The Wendy's Company (NASDAQ:WEN), Novavax, Inc. (NASDAQ:NVAX) - Beacon Chronicle
06/06/16 08:15 AM2 Analyst Biotech Stock Calls With Over 100% Upside Potential -
06/05/16 05:34 PMPerformance Review for Novavax, Inc. (NASDAQ:NVAX) - HNN
06/04/16 08:00 AM[video]'Mad Money' Lightning Round: Take General Mills Over Kellogg -
06/03/16 06:02 PMNoteworthy HC Stocks: Medivation Inc (NASDAQ:MDVN), Novavax, Inc. (NASDAQ:NVAX) - share market updates (press release)
06/03/16 08:24 AMNovavax, Inc. (NASDAQ:NVAX) Quarterly EPS Estimate At $-0.220 - Investor Newswire - Novavax, Inc. (NASDAQ:NVAX) Quarterly EPS Estimate At $-0.220Investor NewswireFirst Call stated that Novavax, Inc. (NASDAQ:NVAX) can touch $14.210 in coming one year. For the next quarter, the per-share earnings target is $-0.220 and for ongoing fiscal at $-0.960. EPS target for next year is $-0.910 versus the mean EPS of $-0 ...and more »
About Novavax

Novavax logoNovavax, Inc. (Novavax) is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company through its recombinant nanoparticle vaccine technology produces vaccine candidates to respond to both known and newly emerging diseases. Its product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). Its lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NVAX
  • CUSIP: 67000210
Key Metrics:
  • Previous Close: $7.17
  • 50 Day Moving Average: $5.96
  • 200 Day Moving Average: $5.80
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.94B
  • Current Quarter EPS Consensus Estimate: $-0.96 EPS
Additional Links:
Novavax (NASDAQ:NVAX) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha